Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.67 |
| ▸ | MAG | P20916 | 7/20 | 0.62 |
| ▸ | SELL | P14151 | 1/20 | 0.60 |
| ▸ | SELP | P16109 | 1/20 | 0.60 |
| ▸ | CD22 | P20273 | 5/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29432525 | 1.00 | SIGLEC7 (0.67) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL31716746 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL29405239 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL29412465 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL19922284 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL24628357 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL804936 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL12454161 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL14362275 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30001019 | 0.96 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286666-A | Separation and purification method and application of oligosaccharide | 中科合生生物工程科技(珠海横琴)有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-113164532-A | H5 functional Bifidobacterium longum subspecies infantis compositions and methods of use | 进化生物系统股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-113163836-A | Compositions and methods for promoting host defense and stimulating, expanding and/or resetting T cell banks | 进化生物系统股份有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-111165825-A | Pre-operative enteral nutritional composition | 江苏西宏生物医药有限公司 | 2020-05-19 | — | — | CN | claimed |
| WO-2005055944-A9 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | CHILDRENS HOSP MEDICAL CENTER (US) | 2005-07-14 | — | — | WO | claimed |
| CN-114144078-B | Nutritional composition comprising milk fat and immunoglobulins | 菲仕兰坎皮纳荷兰公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117957316-A | Fucosyltransferase for converting lactose-N-disaccharide | 因比奥斯公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20230399670-A1 | In vivo synthesis of sialylated compounds | INBIOSE N.V. (BE) | 2023-12-14 | — | — | US | disclosed |
| CN-117222736-A | Cellular production of biological products | 因比奥斯公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117157396-A | Cell production of sialylated di-and/or oligosaccharides | 因比奥斯公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-117157394-A | Fermentation production | 因比奥斯公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116472346-A | Production of sialylated oligosaccharide mixtures by cells | 因比奥斯公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-111935995-A | Nutritional composition, and food and drink composition and formulated milk powder using the same | 森永乳业株式会社 | 2020-11-13 | — | — | CN | disclosed |
| CN-111587376-A | Metabonomics modification of mammalian infants | 进化生物系统股份有限公司 | 2020-08-25 | — | — | CN | disclosed |
| CN-111165825-A | Pre-operative enteral nutritional composition | 江苏西宏生物医药有限公司 | 2020-05-19 | — | — | CN | disclosed |
| US-20190338328-A1 | IN VIVO SYNTHESIS OF SIALYLATED COMPOUNDS | INBIOSE N.V. (BE) | 2019-11-07 | — | — | US | disclosed |
| EP-3562951-A1 | IN VIVO SYNTHESIS OF SIALYLATED COMPOUNDS | Inbiose N.V. (BE) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018122225-A1 | IN VIVO SYNTHESIS OF SIALYLATED COMPOUNDS | INBIOSE N.V. (BE) | 2018-07-05 | — | — | WO | disclosed |
| CN-101415461-A | Adiponectin for treatment of various disorders | CHILDRENS HOSP MEDICAL CT (US) | 2009-04-22 | — | — | CN | disclosed |
| WO-2005055944-A9 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | CHILDRENS HOSP MEDICAL CENTER (US) | 2005-07-14 | — | — | WO | disclosed |